Piper Sandler Boosts Trupanion (NASDAQ:TRUP) Price Target to $45.00

Trupanion (NASDAQ:TRUP) had its target price upped by Piper Sandler from $38.00 to $45.00 in a research report report published on Wednesday morning, Benzinga reports. They currently have a neutral rating on the financial services provider’s stock.

Other analysts also recently issued reports about the company. William Blair started coverage on Trupanion in a report on Friday, July 19th. They issued an outperform rating for the company. Northland Securities raised their price objective on Trupanion from $35.00 to $45.00 and gave the stock a market perform rating in a research report on Thursday, September 19th. Stifel Nicolaus upped their target price on Trupanion from $30.00 to $40.00 and gave the company a hold rating in a report on Monday, September 23rd. Bank of America increased their target price on shares of Trupanion from $47.00 to $56.00 and gave the company a buy rating in a research report on Friday, September 20th. Finally, Evercore ISI raised shares of Trupanion to a strong-buy rating in a research note on Friday, August 9th. Four analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of Moderate Buy and a consensus target price of $41.83.

Trupanion Stock Up 3.6 %

Shares of TRUP opened at $42.84 on Wednesday. The stock has a market capitalization of $1.80 billion, a price-to-earnings ratio of -66.94 and a beta of 1.73. Trupanion has a 52 week low of $19.14 and a 52 week high of $49.14. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.63 and a current ratio of 1.63. The stock has a fifty day moving average of $42.18 and a 200-day moving average of $32.71.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings results on Thursday, August 8th. The financial services provider reported ($0.14) EPS for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.04. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The firm had revenue of $314.80 million for the quarter, compared to analyst estimates of $309.33 million. During the same period last year, the firm posted ($0.33) earnings per share. The business’s revenue for the quarter was up 16.3% on a year-over-year basis. As a group, sell-side analysts anticipate that Trupanion will post -0.34 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CFO Fawwad Qureshi sold 640 shares of the business’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $43.12, for a total transaction of $27,596.80. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, CFO Fawwad Qureshi sold 640 shares of the business’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $43.12, for a total value of $27,596.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the transaction, the chief executive officer now directly owns 99,984 shares in the company, valued at approximately $4,647,256.32. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 8,764 shares of company stock worth $405,238. 5.50% of the stock is owned by corporate insiders.

Institutional Trading of Trupanion

Several hedge funds have recently bought and sold shares of the business. Handelsbanken Fonder AB bought a new position in shares of Trupanion in the third quarter valued at $248,000. EP Wealth Advisors LLC acquired a new position in Trupanion during the 2nd quarter valued at about $294,000. AQR Capital Management LLC raised its stake in shares of Trupanion by 173.8% in the second quarter. AQR Capital Management LLC now owns 43,553 shares of the financial services provider’s stock worth $1,280,000 after purchasing an additional 27,644 shares during the last quarter. Marshall Wace LLP lifted its holdings in shares of Trupanion by 11.9% in the second quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock valued at $32,181,000 after purchasing an additional 116,496 shares in the last quarter. Finally, Public Sector Pension Investment Board grew its holdings in Trupanion by 7.3% during the second quarter. Public Sector Pension Investment Board now owns 79,555 shares of the financial services provider’s stock worth $2,339,000 after buying an additional 5,405 shares in the last quarter.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.